[PDF][PDF] Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
Journal of Pharmacology and Experimental …, 1995 - researchgate.net
ABSTRACT LY303870[(R)-1-[N-(2-methoxybenzyl) acetylamino]-3-(1 H-in-dol-3-yl)-2-[N-(2-
(4-(piperidin-1-yI) piperidin-l-yI) acetyl) amino]-propane] is a new, potent and selective …
(4-(piperidin-1-yI) piperidin-l-yI) acetyl) amino]-propane] is a new, potent and selective …
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist
BD Gitter, RF Bruns, JJ Howbert… - The Journal of …, 1995 - pubmed.ncbi.nlm.nih.gov
LY303870 [(R)-1-[N-(2-methoxybenzyl) acetylamino]-3-(1H-indol-3-yl)-2-[N-(2-(4-(piperidin-
1-yl) piperidin-1-yl) acetyl) amino] propane] is a new, potent and selective nonpeptide …
1-yl) piperidin-1-yl) acetyl) amino] propane] is a new, potent and selective nonpeptide …
[PDF][PDF] Pharmacological Characterization of LY303870: A Novel, Potent and Selective Nonpeptide Substance P (Neurokinin-i) Receptor Antagonist
LM COX, KL NIXON, NR MASON, PW STENGEL - 1995 - Citeseer
ABSTRACT LY303870[(R)-1-[N-(2-methoxybenzyl) acetylamino]-3-(1 H-in-dol-3-yl)-2-[N-(2-
(4-(piperidin-1-yI) piperidin-l-yI) acetyl) amino]-propane] is a new, potent and selective …
(4-(piperidin-1-yI) piperidin-l-yI) acetyl) amino]-propane] is a new, potent and selective …
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
BD Gitter, RF Bruns, JJ Howbert, DC Waters… - The Journal of …, 1995 - europepmc.org
LY303870 [(R)-1-[N-(2-methoxybenzyl) acetylamino]-3-(1H-indol-3-yl)-2-[N-(2-(4-(piperidin-
1-yl) piperidin-1-yl) acetyl) amino] propane] is a new, potent and selective nonpeptide …
1-yl) piperidin-1-yl) acetyl) amino] propane] is a new, potent and selective nonpeptide …
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
BD Gitter, RF Bruns, JJ Howbert, DC Waters… - … of Pharmacology and …, 1995 - ASPET
LY303870 [(R)-1-[N-(2-methoxybenzyl) acetylamino]-3-(1H-indol-3-yl)-2-[N-(2-(4-(piperidin-
1-yl) piperidin-1-yl) acetyl) amino] propane] is a new, potent and selective nonpeptide …
1-yl) piperidin-1-yl) acetyl) amino] propane] is a new, potent and selective nonpeptide …
[引用][C] Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist
BD GITTER - J Pharmacol Exp Ther, 1995 - cir.nii.ac.jp
Pharmacological characterization of LY303870 : a novel, potent and selective nonpeptide
substance P (neurokinin-1) receptor antagonist | CiNii Research CiNii 国立情報学研究所 …
substance P (neurokinin-1) receptor antagonist | CiNii Research CiNii 国立情報学研究所 …
[引用][C] Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
BD GITTER - J Pharmacol Exp Ther, 1995 - cir.nii.ac.jp
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide
substance P (neurokinin-1) receptor antagonist. | CiNii Research CiNii 国立情報学研究所 学術 …
substance P (neurokinin-1) receptor antagonist. | CiNii Research CiNii 国立情報学研究所 学術 …